Depression and Anxiety Trial, Recruiting (NCT07430488)

Depression and Anxiety Trial, Recruiting NCT07430488 Sponsor: Groupe SantéCité SantéCité Enseignement-Recherche-Innovation (GCS SCERI) Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT07430488 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women aged 18 years old up to (but not including) 43 years old
People who have been recommended a hysterectomy (surgical removal of the uterus) for a non-cancerous condition
People who have given clear verbal agreement to take part in the trial
People who are covered by the French social security (public health insurance) system
People who are able to read and understand French well enough to read a French book within the timeframes required by the study

Who may not be able to join:

Women who have suspected uterine (womb) cancer or high-grade abnormal cells (precancerous changes)
Women who are currently taking part in, or have taken part in, another clinical trial involving a medical intervention within the last 30 days
Women who are currently pregnant, breastfeeding, or have recently given birth
People who are under legal guardianship or court-ordered protection, people who have been detained by a legal or government order, or people who are in hospital without having consented to being there
People who do not have a sufficient level of French language ability

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07430488

Sponsor: Groupe SantéCité SantéCité Enseignement-Recherche-Innovation (GCS SCERI)

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

More information: https://clinicaltrials.gov/study/NCT07430488

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women aged 18 years old up to (but not including) 43 years old
People who have been recommended a hysterectomy (surgical removal of the uterus) for a non-cancerous condition
People who have given clear verbal agreement to take part in the trial
People who are covered by the French social security (public health insurance) system
People who are able to read and understand French well enough to read a French book within the timeframes required by the study

Who may not be able to join:

Women who have suspected uterine (womb) cancer or high-grade abnormal cells (precancerous changes)
Women who are currently taking part in, or have taken part in, another clinical trial involving a medical intervention within the last 30 days
Women who are currently pregnant, breastfeeding, or have recently given birth
People who are under legal guardianship or court-ordered protection, people who have been detained by a legal or government order, or people who are in hospital without having consented to being there
People who do not have a sufficient level of French language ability

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Groupe SantéCité SantéCité Enseignement-Recherche-Innovation (GCS SCERI)

Registry

ClinicalTrials.gov

Start date

13 May 2026

Est. completion

1 January 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Adaptive regulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov